United States - English - NLM (National Library of Medicine)

oceanside pharmaceuticals - luliconazole (unii: re91an4s8g) (luliconazole - unii:re91an4s8g) - luliconazole cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms trichophyton rubrum and epidermophyton floccosum . none. risk summary there are no available data with luliconazole cream, 1% use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. in animal reproduction studies with pregnant rats and rabbits, there were no adverse developmental effects observed with subcutaneous administration of luliconazole during organogenesis at doses up to 3 and 24 times, respectively, the maximum recommended human dose (mrhd) [see data] . the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively.

United States - English - NLM (National Library of Medicine)

bausch health us, llc - luliconazole (unii: re91an4s8g) (luliconazole - unii:re91an4s8g) - luliconazole 10 mg in 1 g - luzu (luliconazole) cream, 1% is indicated for the topical treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organisms trichophyton rubrum and epidermophyton floccosum . none. risk summary there are no available data with luzu cream, 1% use in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. in animal reproduction studies with pregnant rats and rabbits, there were no adverse developmental effects observed with subcutaneous administration of luliconazole during organogenesis at doses up to 3 and 24 times, respectively, the maximum recommended human dose (mrhd) [see data] . the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. d

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - luliconazole (unii: re91an4s8g) (luliconazole - unii:re91an4s8g) -

Kenya - English - Pharmacy and Poisons Board

tiba healthcare ltd insales complex, mombasa road p.o box 243-00623 - luliconazole - cream - luliconazole cream 1% w/w - luliconazole

Kenya - English - Pharmacy and Poisons Board

klm laboratories pvt ltd. 1004, hubtown viva, western express highway, - luliconazole - cream - luliconazole 1.0% w/w, preservative: benzyl… - luliconazole

Kenya - English - Pharmacy and Poisons Board

yash pharma laboratories pvt. ltd. khasara no.19-m,village:raipur, - luliconazole - cream - luliconazole……………….1%w/w cream base…………………… q.s. - luliconazole

Kenya - English - Pharmacy and Poisons Board

galaxy pharmaceutical limited p.o. box 39107-00623, nairobi - luliconazole - cream - luliconazole 1.0% w/w, - luliconazole

Kenya - English - Pharmacy and Poisons Board

luliconazole - cream - luliconazole ……1.0% w/w - luliconazole

Kenya - English - Pharmacy and Poisons Board

luliconazole - medicated chewing-gum - luliconazole 1.0%w/v - luliconazole

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

replek farm ltd - fluconazole - capsules - 150mg